282 related articles for article (PubMed ID: 15690967)
41. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study.
Giustozzi M; Vedovati MC; Verso M; Scrucca L; Conti S; Verdecchia P; Bogliari G; Pierpaoli L; Agnelli G; Becattini C
Int J Cardiol; 2019 Apr; 281():56-61. PubMed ID: 30712846
[TBL] [Abstract][Full Text] [Related]
42. Burden of Premature Atrial Complexes and Risk of Recurrent Stroke and Death in Patients with Mild to Moderate Ischemic Stroke.
Sejr MH; May O; Damgaard D; Bruun NH; Nielsen JC
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104490. PubMed ID: 31839547
[TBL] [Abstract][Full Text] [Related]
43. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.
Lancet; 1993 Nov; 342(8882):1255-62. PubMed ID: 7901582
[TBL] [Abstract][Full Text] [Related]
44. Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.
Becattini C; Dentali F; Camporese G; Sembolini A; Rancan E; Tonello C; Manina G; Padayattil S; Agnelli G
Atherosclerosis; 2018 Apr; 271():177-181. PubMed ID: 29524860
[TBL] [Abstract][Full Text] [Related]
45. [Neurological events in patients with atrial fibrillation: outcome and preventive practices].
Carlsson J; Miketic S; Flicker E; Erdogan A; Haun S; Cuneo A; Tebbe U
Z Kardiol; 2000 Dec; 89(12):1090-7. PubMed ID: 11201024
[TBL] [Abstract][Full Text] [Related]
46. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
47. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
48. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
49. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
[TBL] [Abstract][Full Text] [Related]
50. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
Int J Cardiol; 2017 Apr; 232():134-139. PubMed ID: 28132778
[TBL] [Abstract][Full Text] [Related]
51. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
Benavente O; Hart R; Koudstaal P; Laupacis A; McBride R
Cochrane Database Syst Rev; 2000; (2):CD001927. PubMed ID: 10796453
[TBL] [Abstract][Full Text] [Related]
52. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
[TBL] [Abstract][Full Text] [Related]
53. Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.
Eriksson SE
Brain Behav; 2017 Jan; 7(1):e00603. PubMed ID: 28127521
[TBL] [Abstract][Full Text] [Related]
54. Should stroke subtype influence anticoagulation decisions to prevent recurrence in stroke patients with atrial fibrillation?
Evans A; Perez I; Yu G; Kalra L
Stroke; 2001 Dec; 32(12):2828-32. PubMed ID: 11739981
[TBL] [Abstract][Full Text] [Related]
55. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500
[TBL] [Abstract][Full Text] [Related]
56. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
57. Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.
Chen PC; Lip GY; Yeh G; Lin HJ; Chien KL
PLoS One; 2015; 10(4):e0125257. PubMed ID: 25923742
[TBL] [Abstract][Full Text] [Related]
58. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
Rost NS; Giugliano RP; Ruff CT; Murphy SA; Crompton AE; Norden AD; Silverman S; Singhal AB; Nicolau JC; SomaRaju B; Mercuri MF; Antman EM; Braunwald E;
Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994
[TBL] [Abstract][Full Text] [Related]
59. Atrial Fibrillation Diagnosis Timing, Ambulatory ECG Monitoring Utilization, and Risk of Recurrent Stroke.
Lip GY; Hunter TD; Quiroz ME; Ziegler PD; Turakhia MP
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28096204
[TBL] [Abstract][Full Text] [Related]
60. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]